Physician profile

James W Adams

Pulmonary Disease · Memphis, TN

NPI 1649275322

$9,112.48

in general payments reported to CMS, 2019-2025

18 companies · $3,003 in 2025

The $3,003 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,994.40

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $2,946.36 2019-2025 Breztri, Fasenra, Tezspire
Glaxosmithkline, LLC. $2,740.60 2019-2025 Nucala, Arexvy, Trelegy Ellipta
Genzyme Corporation $889.64 2021-2025
Philips North America LLC $491.44 2019-2025 Vest Therapy Und, (Ak6) Vest Therapy, Reusable Vest
Mylan Specialty L.P. $452.85 2019-2024 Yupelri
Verona Pharma, INC. $395.00 2025 Ohtuvayre
Regeneron Healthcare Solutions, INC. $393.49 2022-2025 Dupixent
Sunovion Pharmaceuticals INC. $192.42 2019-2021
Insmed, INC. $182.21 2025 Arikayce, Brinsupri
Viatris Specialty LLC $91.36 2025 Yupelri
Teva Pharmaceuticals USA, INC. $82.63 2020-2021
Inogen, INC. $62.85 2022-2023 Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen At Home Stationary Concentrator
Mallinckrodt Hospital Products INC. $60.01 2023-2024 Acthar
Boehringer Ingelheim Pharmaceuticals, INC. $51.23 2021-2022
Smith+Nephew, INC. $23.86 2019
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Electromed, INC. $22.02 2023 Smartvest
Baxter Healthcare $19.08 2025 Hillrom - Vest System Model 105 Home Care
Jazz Pharmaceuticals INC. $15.43 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James W Adams

$9,112.48

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $3,003 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/74829/james-w-adams

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.